Press Releases
- Active Biotech expands US collaboration to advance tasquinimod clinical development in myelofibrosis
- First patient dosed in the amended HO172 clinical study of tasquinimod in myelofibrosis
- Number of shares and votes in Active Biotech
- Active Biotech announces timetable for reverse share split
- Annual General Meeting of Active Biotech AB